Terns Pharmaceuticals (TERN)
(Delayed Data from NSDQ)
$4.75 USD
+0.06 (1.28%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $4.75 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/20/2024
Time: -- |
3/2024 | $-0.36 | -18.31% |
Earnings Summary
For their last quarter, Terns Pharmaceuticals (TERN) reported earnings of -$0.29 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for TERN's next earnings release expected on May 20, 2024. For the next earning release, we expect the company to report earnings of -$0.36 per share, reflecting a year-over-year decrease of 16.13%.
Earnings History
Price & Consensus
Zacks News for TERN
Take the Zacks Approach to Beat the Market: Uber, Baidu, AssetMark in Focus
TERN: What are Zacks experts saying now?
Zacks Private Portfolio Services